Mobile apps: Proposed FDA rule will disrupt industry
The Food and Drug Administration's recent guidance on how it might regulate mobile health applications used by physicians and consumers will affect only a small portion of the apps on the market, the agency said. However, the FDA's expanded regulation of device-related software will affect device manufacturers and the growing number of firms marketing health apps for smartphones and tablets. "The majority of the folks who I've been dealing with do fall within the scope of that guidance document," said Bradley Thompson, a New York attorney specializing in medical device regulation.
- Providers Lag as Consumers Set Agenda
- Look Beyond Nurse-Patient Ratios
- Esther Dyson Launches Population Health Challenge
- Reform Puts Vise Grips on Physicians
- Crisis Spurs Healthcare Payment Reform in Arkansas
- Hospital Groups Back NQF Report on Patient Sociodemographics
- ICD-10 Delay Alters Provider, Vendor Prep
- NPP Demand Rising Under Value-Based Care Models
- Medicare Opt-Out a Viable Physician Strategy
- Reduce Readmissions by Activating Patients to Do 'Self-Care'